Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019
Current assets:
Cash and cash equivalents	$ 61,854	$ 73,228
Settlement Assets, Current	13,423	25,607
Short-term investments	9,236	4,443
Restricted Cash and Cash Equivalents, Current	24,756	35,051
Funds Held for Clients	5,293	4,966
Trade accounts receivable, less allowances of $20,179 and $21,696, respectively	135,889	153,565
Other current assets	68,667	67,074
Total current assets	319,118	363,934
Property and equipment, net	46,831	48,421
Operating Lease, Right-of-Use Asset	16,639	19,544
Goodwill	921,367	952,404
Intangibles, net	42,749	46,955
Indefinite-lived intangibles	42,055	42,055
Capitalized Software Development Costs for Software Sold to Customers	19,536	19,183
Deferred tax asset, net	66,842	69,227
Other assets	28,473	29,896
Total assets	1,503,610	1,591,619
Current liabilities:
Accounts payable and accrued liabilities	70,102	84,735
Settlement Liabilities, Current	8,720	12,196
Accrued payroll and related benefits	9,356	8,755
Bank Overdrafts	2,746	28,352
Funds Held for Clients, Liability	5,293	4,966
Short Term Debt, net	1,050	1,167
Current portion of long term debt and financing lease obligation, net of deferred financing costs of $734 and $575, respectively	23,809	22,091
Operating Lease, Liability, Current	5,268	5,955
Derivative Financial Instrument, Liabilities, Fair Value Disclosure, Current	8,111	8,621
Deferred Revenue, Current	29,814	28,712
Other current liabilities	22,892	29,335
Total current liabilities	187,161	234,885
Revolving line of credit	438,037	438,037
Long-term Debt and Capital Lease Obligations, net	248,912	254,467
Other liabilities	35,326	40,339
Derivative Financial Instrument, Liabilities, Fair Value Disclosure, Noncurrent	1,405	1,474
Deferred Revenue, Noncurrent	8,649	8,541
Operating Lease, Liability, Noncurrent	11,169	13,196
Deferred tax liability, net	1,235	1,235
Total liabilities	931,894	992,174
Commitments and Contingencies
Stockholders’ equity:
Preferred stock, $0.10 par value, 500,000 shares authorized, no shares issued and outstanding at March 31, 2020 and December 31, 2019	0	0
Series Y Preferred Stock, Value, Issued	0	0
Common stock, $0.10 par value, 220,000,000 shares authorized, 30,475,994 issued and outstanding, at March 31, 2020, and 30,492,044 issued and outstanding at December 31, 2019	3,048	3,049
Additional paid-in capital	8,211	6,960
Retained Earnings (Accumulated Deficit)	639,596	618,503
Accumulated other comprehensive loss	(128,192)	(78,398)
Total stockholders’ equity	522,663	550,114
Stockholders' Equity Attributable to Noncontrolling Interest	49,053	49,331
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest	571,716	599,445
Total liabilities and stockholders’ equity	$ 1,503,610	$ 1,591,619